Saveria Capria

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Is There Still a Role for Autologous Stem Cell Transplantation in Older Adults with AML?

Is There Still a Role for Autologous Stem Cell Transplantation in Older Adults with AML?

Journal: Hematology reports

Published: April 24, 2026

Associations Between Sex, Disease Features and Outcome in Patients With Acute Myeloid Leukemia: A Sex-Stratified Analysis of the GIMEMA AML1310 Trial.

Associations Between Sex, Disease Features and Outcome in Patients With Acute Myeloid Leukemia: A Sex-Stratified Analysis of the GIMEMA AML1310 Trial.

Journal: American journal of hematology

Published: November 21, 2025

Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia.

Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia.

Journal: The oncologist

Published: September 23, 2025

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.

Journal: European journal of haematology

Published: July 23, 2025

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Journal: Blood advances

Published: May 19, 2025

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Journal: Blood advances

Published: May 19, 2025

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Journal: Blood advances

Published: May 19, 2025

Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT.

Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT.

Journal: BMC cancer

Published: September 26, 2024

Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.

Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.

Journal: Blood advances

Published: September 23, 2024

Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia.

Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia.

Journal: Cancers

Published: August 09, 2024

Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years.

Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years.

Journal: Cancers

Published: June 28, 2024

Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time.

Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time.

Journal: Annals of hematology

Published: June 25, 2024

Showing 1-12 of 58

Last Updated: 09/26/2026